Who Owns GSK Stock?
NYSE: GSKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 46.50 0.00%
Ownership breakdown
- Held by institutions
- 17.47%
- Held by insiders
- 0.06%
- Institutional holders
- 1,207
- Institutions 17.5%
- Insiders 0.1%
- Public and other 82.5%
Who owns GSK stock?
Institutional investors own about 17.5% of GSK's shares, spread across 1,207 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.06% of GSK.
The largest institutional holders are FMR, LLC (3.21%), Dodge & Cox Inc. (2.38%) and Fisher Asset Management, LLC (1.77%). Together, the top 10 institutions control 11.0% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their GSK positions and 8 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of GSK
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 64.96M | 3.21% | -4.0% |
| Dodge & Cox Inc. | 48.20M | 2.38% | -17.8% |
| Fisher Asset Management, LLC | 35.72M | 1.77% | +3.5% |
| Primecap Management Company | 25.18M | 1.24% | -0.1% |
| Wellington Management Group, LLP | 11.40M | 0.56% | -2.7% |
| JTC Employer Solutions Trustee Ltd. | 8.59M | 0.42% | -5.0% |
| Morgan Stanley | 7.66M | 0.38% | -30.6% |
| Royal Bank of Canada | 7.59M | 0.38% | +1.1% |
| Price (T.Rowe) Associates Inc | 6.92M | 0.34% | -5.5% |
| Acadian Asset Management. LLC | 6.66M | 0.33% | -43.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of GSK
| Fund | Shares | % Held |
|---|---|---|
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 35.57M | 1.76% |
| VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund | 18.17M | 0.90% |
| VANGUARD WELLINGTON FUND | 9.66M | 0.48% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 7.98M | 0.39% |
| Fidelity Hastings Street Trust-Fidelity Series Large Cap Stock Fund | 4.58M | 0.23% |
| Fidelity Devonshire Trust-Fidelity Series Value Discovery Fund | 3.95M | 0.20% |
| Dodge & Cox Funds-Dodge & Cox Balanced Fund | 3.60M | 0.18% |
| VANGUARD FENWAY FUNDS-Vanguard PRIMECAP Core Fund | 3.55M | 0.18% |
| Fidelity Securities Fund-Fidelity Growth & Income Portfolio | 3.44M | 0.17% |
| TR PRICE-Price (T.Rowe) International Value Equity Trust | 3.36M | 0.17% |
Frequently asked questions
Who is the largest shareholder of GSK?
FMR, LLC is the largest institutional shareholder of GSK, owning 3.21% of shares outstanding (64.96M shares) as of its latest 13F filing.
What percentage of GSK is owned by institutions?
Institutions own about 17.5% of GSK shares and 17.5% of the public float.
How much of GSK do insiders own?
Insiders, such as officers and directors, own about 0.06% of GSK shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.